Clinical trial · Interventional
Decreasing Long-term Opioid Use in Cancer Survivors
Creating a Pathway for Disease-Free Cancer Survivors to Decrease Long-term Opioid Use
NCT05067556CI-TRIAL-00122608suspendedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Insufficient staffing
Summary
Brief summary (as posted)
This is a feasibility pilot trial assessing a behavioral intervention for chronic pain among disease-free cancer survivors to decrease long-term opioid dependence.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Pain | — | UNRESOLVED | — |
| Chronic Pain | — | UNRESOLVED | — |
| Pain | — | UNRESOLVED | — |
| Survivorship | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acceptance and Commitment Therapy for chronic pain (ACT-CP) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Acceptance and Commitment Therapy for Chronic Pain (ACT-CP)
- interventionNames
- Behavioral: Acceptance and Commitment Therapy for chronic pain (ACT-CP)
Primary outcomes (5)
- measure
- Recruitment yield of participants contacted
- timeFrame
- 12 Months
- description
- Study feasibility will be assessed by tracking the number of patients contacted
- measure
- Recruitment yield of participants consented
- timeFrame
- 12 Months
- description
- Study feasibility will be assessed by tracking the number of participants that consent to enroll in the trial.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of cancer of any type, currently in remission, having completed active primary therapy. Patients on oral adjuvant hormone therapy will still be eligible. * Completed active therapy must have been curative in intent (for example stage IV cancer patients such as head and neck cancer patients treated with curative intent are eligible). * Self-reported cancer pain for \>= 3 months * Opioid use \>= 5MME/day (morphine milligram equivalents) as prescribed by physician for cancer-related pain for at least 6 months beyond completion of their cancer treatment * VCUHealth system patient Exclusion Criteria: * History of opioid use prior to cancer diagnosis * Anyone with prior history of substance use disorder or currently enrolled in a methadone program * Anyone with schizophrenia or bipolar disorder * Current utilization of psychotherapy services for pain, depression, anxiety, and/or PTSD * Cognitive concerns that would prevent meaningful engagement in treatment * Inability to converse in English * Lack of working telephone and Internet connection (must have at least one or the other) * Anyone found to have progression of cancer * Anyone diagnosed with cancer recurrence or new cancer during their study period * Documented diagnosis of or positive screen for current substance use disorder (score \>5 on the Drug Abuse Screening Test-10 \[DAST-10\]) * Anyone scoring \>=8 on ORT indicating very high risk for opioid abuse
References
Publications (0)
Data not yet available
No reference posted for this study.